BIOMAT Database Logo BIOMAT Database Logo

Unique ganglioside binding by botulinum neurotoxins C and D-SA. 2011

Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

The botulinum neurotoxins (BoNTs) are the most potent protein toxins for humans. There are seven serotypes of BoNTs (A-G), based on a lack of cross-antiserum neutralization. The BoNT/C and BoNT/D serotypes include mosaic toxins that are organized as D-C and C-D toxins. One BoNT D-C mosaic toxin, BoNT/D-South Africa (BoNT/D-SA), was not fully neutralized by immunization with a vaccine composed of either prototype BoNT/C-Stockholm or BoNT/D-1873. Whereas several BoNT serotypes utilize dual receptors (gangliosides and proteins) to bind to and enter neurons, the basis for BoNT/C and BoNT/D entry into neurons is less well understood. Recent studies solved the crystal structures of the receptor-binding domains of BoNT/C, BoNT/D, and BoNT/D-SA. Comparative structural analysis showed that BoNT/C, BoNT/D and BoNT/D-SA lacked components of the ganglioside-binding pocket that exists within other BoNT serotypes. With the use of structure-based alignments, biochemical analyses, and cell-binding approaches, BoNT/C and BoNT/D-SA have been shown to possess a unique ganglioside-binding domain, the ganglioside-binding loop. Defining how BoNTs enter host cells provides insights towards understanding the evolution and extending the potential therapeutic and immunological values of the BoNT serotypes.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
October 2005, The Journal of biological chemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Binding of botulinum and tetanus neurotoxins to ganglioside GT1b and derivatives thereof.
September 1991, Journal of neurochemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Unique ganglioside recognition strategies for clostridial neurotoxins.
September 2011, The Journal of biological chemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
March 2013, Veterinary microbiology,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins.
May 2007, Vaccine,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Unique substrate recognition by botulinum neurotoxins serotypes A and E.
April 2006, The Journal of biological chemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Ganglioside-induced adherence of botulinum and tetanus neurotoxins to adducin.
June 1996, Journal of neurochemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Synaptotagmin Binding to Botulinum Neurotoxins.
February 2020, Biochemistry,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Peculiar binding of botulinum neurotoxins.
February 2007, ACS chemical biology,
Abby R Kroken, and Andrew P-A Karalewitz, and Zhuji Fu, and Michael R Baldwin, and Jung-Ja P Kim, and Joseph T Barbieri
Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
August 1998, Microbial pathogenesis,
Copied contents to your clipboard!